Skip to main content
. Author manuscript; available in PMC: 2017 Jan 3.
Published in final edited form as: ACS Appl Mater Interfaces. 2016 Dec 2;8(49):33412–33422. doi: 10.1021/acsami.6b08153

Figure 3.

Figure 3

Time dependent cellular uptake of gemcitabine and antisense-miRNA-21 co-encapsulated PEGylated-PLGA-NPs in Hep3B cells. (a) Confocal microscopic images (red, Cy5-fluorescence from co-encapsulated Cy5-antisense-miRNA-21; blue, DAPI nuclear stain). (b) FACS analysis of Cy5-antisense-miRNA-21 co-encapsulated NPs treated Hep3B cells.